phase iii tropics-04 trial: sacituzumab govitecan vs treatment of choice in advanced muc
Published 5 months ago • 195 plays • Length 1:13Download video MP4
Download video MP3
Similar videos
-
5:07
tropics-02: sacituzumab govetican improves pfs versus physicians choice for hr /her2- mbc
-
1:08
ascent-05: sacituzumab govitecan and pembrolizumab in tnbc
-
1:56
trofuse-010: sacituzumab tirumotecan in hr /her2- metastatic breast cancer
-
1:16
antibody-drug conjugates in advanced urothelial cancer: sacituzumab govitecan
-
3:03
phase ii trial of patritumab deruxtecan in metastatic breast cancer
-
8:15
esmo 2020: meta. triple negativer brustkrebs (tnbc): ascent-studie mit sacituzumab govitecan (sg)
-
5:06
miracle cancer drug, trodelvy, changing lives at it's put on the pharmaceutical benefits scheme
-
11:07
liquid biopsy can help guide cancer treatment
-
4:25
ascent: sacituzumab govitecan shows promise in mtnbc patients
-
1:39
phase ib trial of bintrafusp alfa for advanced urothelial cancer
-
4:59
pooled results of two randomized phase 3 trials evaluating vp-102
-
5:06
safety outcomes in the phase iii monarche trial of abemaciclib et in hr , her2- breast cancer
-
3:42
exciting ongoing trials in urothelial cancer
-
3:59
sacituzumab govitecan for treatment-refractory metastatic breast cancer
-
4:04
efficacy of sacituzumab govitecan by trop-2 expression in metastatic urothelial carcinoma
-
1:34
phase ii trial addresses challenges with combination maintenance in urothelial cancer
-
1:47
results of a phase iii trial on ct-p6, a trastuzumab biosimilar candidate, in early breast cancer
-
1:25
dr. debu tripathy reviews the phase iii confirm trial
-
5:06
phase 3 checkmate - 214
-
1:50
phase i/ii trial stx-478, a mutant-selective pi3kα inhibitor, in advanced solid tumor
-
1:25
dr. jhaveri on results of taselisib in pik3ca-mutated metastatic solid tumors
-
1:58
dr. tolaney on presence of pik3ca and esr1 mutations in monarch 2 trial in breast cancer